Exelixis’s Cabometyx continues to drive revenue growth, prompting a raised 2024 forecast to $2.15–$2.2 billion. Read my EXEL ...
(Nasdaq: EXEL) today reported financial results for the third quarter of 2024, provided an update on progress toward achieving key corporate objectives, and detailed its recent and anticipated ...
Austria, Belgium, Czechia, Finland, Northern Ireland, Norway, Poland, Portugal, Republic of Ireland, Scotland, Serbia, Sweden, Ukraine and Wales are into round 2. The ...
Keytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight cancer. In India, its high cost limits access. With patents expiring soon, ...
The purpose of displaying the NSQ list is to make stakeholders aware about the NSQ batches identified in the market, the drug regulator stated. (Image Credits: Pixabay) The Central Drugs Standard ...
Copyright 2024 The Associated Press. All Rights Reserved. European Commission President Ursula von der Leyen, left, shakes hands with Serbian President Aleksandar ...
With these approvals, KEYTRUDA is now authorized for 30 indications in the EU, including five in gynecologic cancers, Merck said in a statement. RAHWAY: Merck, also known as MSD outside the US and ...
Merck's diversified pipeline includes promising oncology candidates and a new pneumococcal vaccine, but lacks a ready-made Keytruda replacement. Investors should monitor R&D updates closely ...
Merck, known as MSD outside of the United States and Canada, announced that the European Commission (EC) has approved two new indications for Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, in ...
In the trailer for Showtime’s espionage thriller The Agency, a spy learns that living a double life has consequences. While working as a stealth CIA agent, Martian (Michael Fassbender) is ...
“The Agency” has set its official premiere date on Paramount+ with Showtime. The first two episodes of the espionage thriller series will be available to stream and on demand on Nov. 29.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback